Fuan Pharmaceutical (300194.SZ): Injection for encontrar obtained drug registration certificate
09/04/2025
GMT Eight
Fuan Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary Fuan Pharmaceutical Group Yantai Zhichu Pharmaceutical Co., Ltd. ("Zhichu Pharmaceutical") recently received a drug registration certificate issued by the National Medical Products Administration for the drug named: Teicoplanin for Injection.
Teicoplanin for Injection is used to treat various severe infections caused by Gram-positive bacteria, including severe Staphylococcus infections that cannot be treated with penicillin or cephalosporin antibiotics, or have failed treatment with these antibiotics, or Staphylococcus infections resistant to other antibiotics.